Health & Pharmaceuticals›
Pharmaceutical Products & Market›
Projected top pharmaceutical companies based on new sales 2018-2019

Projected top pharmaceutical companies based on new sales 2018-2019

Name: Projected top pharmaceutical companies based on new sales 2018-2019
Creator: Statista

Top pharmaceutical companies in 2019 based on sales increase over 2018 (in billion U.S. dollars)

This statistic depicts the projected top pharmaceutical companies based on 2019 sales increase over 2018. According to the source, AstraZeneca will have the largest new sales in 2019 with a 2.26 billion dollars increase over 2018.

Top pharmaceutical companies in 2019 based on sales increase over 2018 (in billion U.S. dollars)

Loading statistic...

About this statistic

Show source

Download Settings Share

Description

Source

More information

Source

More information

Other statistics on the topic

Research and development in European pharmaceutical industry by country 2016

Leading 18 European pharmaceutical companies by retail sales 2015

VAT rate on prescription-only drugs in Europe 2018

Market share of generics in European countries 2016

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Premium Account

Your perfect start with Statista

Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

* All products require an annual contract.
Prices do not include sales tax.

Leading companies trust Statista:

I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Pharmaceutical trends in Europe"

Overview

The most important statistics

Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*European Union: share of GDP expenditure on research and development 2000-2017
Pharmaceutical research and development spending in selected European countries in 2016 (in million euros)Research and development in European pharmaceutical industry by country 2016
Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2003 and 2017Yearly growth rate of R&D spending in pharmaceutical industry 2003-2017

European Pharmaceutical companies

Self-medication market

Employment

Clinical Trials

Discover Statista

Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics

Topics

Studies

Statistics on "Pharmaceutical trends in Europe"

Related topics

About Statista

Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.

Internet & Telecommunications

Consumer Goods & FMCG

Retail & Trade

Travel, Tourism & Hospitality

Society

Transportation & Logistics

Learn more about how Statista can support your business.

Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

	Basic Account	Instant Access Premium Account
Our services Click the question mark for further information	Free	$49 per month* (billed annually)
Basic statistics
Premium statistics

Graph download
Download PDF
Excel download
	Register	Purchase now

*Duration: 12 months, billed annually, single license

	Sales increase in billion U.S. dollars
AstraZeneca	2.26
Celgene	1.93
Novartis	1.45
Bristo-Myers Squibb	1.43
AbbVie	1.38

	Sales increase in billion U.S. dollars
AstraZeneca	2.26
Celgene	1.93
Novartis	1.45
Bristo-Myers Squibb	1.43
AbbVie	1.38